Drug Firm to Pay Feds $280 Million to Settle Pricing Claims



In a whistleblower suit, the U.S. Justice Department accused Dey Pharma  of violating the False Claims Act by artificially inflating prices for drugs reimbursed with federal funds.


Name:
E-mail:
Website:  
Please enter your comment below:
Please enter the text below:

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.